Adrenomyeloneuropathy (AMN)
is a rare inherited metabolic disorder that is
a form of Adrenoleukodystrophy (ALD), which occurs
in young men. AMN characterized by the loss of
the fatty covering (myelin sheath) on nerve fibers
within the brain (cerebral demyelination) and
the progressive degeneration of the adrenal gland
(adrenal atrophy). Neurological disability in
AMN is slowly progressive over several decades.
AMN interests the wider neurologic community because
of its similarities to Multiple Sclerosis (MS).